Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Imagion Biosystems’ cancer tumour detection tech produces early positive results
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Imagion Biosystems’ cancer tumour detection tech produces early positive results
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Imagion Biosystems’ cancer tumour detection tech produces early positive results
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Imagion Biosystems’ cancer tumour detection tech produces early positive results
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Imagion Biosystems’ cancer tumour detection tech produces early positive results
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Imagion Biosystems’ cancer tumour detection tech produces early positive results
    Imagion Biosystems’ cancer tumour detection tech produces early positive results
    • News

  • Austco Healthcare wins $3.8 million contract to update nurse call system for two Singapore hospitals
    Austco Healthcare wins $3.8 million contract to update nurse call system for two Singapore hospitals
    • News

  • Volpara cash flow positive for fourth consecutive quarter as demand for early breast cancer detection tech grows
    Volpara cash flow positive for fourth consecutive quarter as demand for early breast cancer detection tech grows
    • News

  • Careteq signs agreement with National Seniors Australia to provide GPS trackers to ageing population
    Careteq signs agreement with National Seniors Australia to provide GPS trackers to ageing population
    • News

  • Drug that stops growth of cancerous cells shows positive results
    • News

    Drug that stops growth of cancerous cells shows positive results

    12-year-old Louie the beagle had little time left once the vet diagnosed his lymphoma. To avoid the side effects of steroids and chemo, his parents took a chance on biotech company PharmAust’s (ASX: PAA) monepantel (MPL) drug. Within a few weeks, Louie’s lymph nodes shrunk and he enjoyed a good quality of life. Today, he

    Read More
    Public
  • The Original Juice Co signs distribution deal to juice up Asia
    • News

    The Original Juice Co signs distribution deal to juice up Asia

    A nutritious morning staple that has been around since the 1900s, orange juice has surely earned its place on breakfast tables almost everywhere around the globe. This has prompted juice manufacturers like The Original Juice Co (ASX: OJC) (formerly the Food Revolution Group) to maximise commercial opportunities on a global scale, particularly Mainland China which

    Read More
    Public
  • EZZ teams up with Aubay to expand reach in China, expects annual revenue to grow by $16 million
    • News

    EZZ teams up with Aubay to expand reach in China, expects annual revenue to grow by $16 million

    Nutritional supplements company EZZ Life Science Holdings (ASX: EZZ), a genomic life science company, has entered into an agreement with service management company Aubay Pty. Ltd. trading as HIC for the exclusive distribution rights of two EZZ-branded products.  The two-year agreement is expected to generate additional annual revenues of at least $16 million for EZZ

    Read More
    Public
  • oOh! Media has an oOps! Moment as 40% share price decline raises questions from ASX
    • News

    oOh! Media has an oOps! Moment as 40% share price decline raises questions from ASX

    Being an ASX-listed company doesn’t stop at your IPO. There’s a list of rules and regulations that many seem to have found a way around, thus irking the ASX. On May 3, out-of-home advertising company oOh! Media (ASX: OML) published an investor presentation resulting in a share price dump. Whether it was planned or not,

    Read More
    Public
  • Halo brings on Modus for strategic review amid multi-million dollar Fonterra deal
    • News

    Halo brings on Modus for strategic review amid multi-million dollar Fonterra deal

    A strategic review rarely signals good things. Most times, it reveals the many cracks within the company. But if you’re lucky, the review will end with only great things to say about it. Amid a multi-million dollar deal with dairy nutrition company Fonterra, the functional beverage brand Halo Food Co (ASX: HLF) has decided to

    Read More
    Public
  • Archer ticks off quantum milestones with zero debt and the backing of world’s largest semiconductor foundry
    • News

    Archer ticks off quantum milestones with zero debt and the backing of world’s largest semiconductor foundry

    In a trillion-dollar industry so inundated by competitors, Aussie semiconductor company Archer Materials (ASX: AXE) has managed to stand out and make a name for itself with its unique qubit processor technology, the 12CQ chip, which is paving the path for mobile quantum computing devices. It has the backing of the largest semiconductor chip producer,

    Read More
    Public
  • Medibank receives class action lawsuit by Slater & Gordon
    • News

    Medibank receives class action lawsuit by Slater & Gordon

    On October 11, 2022, health insurance provider Medibank (ASX: MPL) noticed a security breach in its system. A criminal was able to access Medibank’s systems by using a stolen username and password from a third-party IT service provider. They were able to obtain more credentials and access multiple systems. This was possible due to a

    Read More
    Public
  • Incannex to launch psychedelic-assisted clinics across Australia
    • News

    Incannex to launch psychedelic-assisted clinics across Australia

    In February 2023, Australia became the first country to accept psychedelics, i.e. hallucinogenic drugs, as medicine. It approved the use of MDMA and psilocybin, typically known as mushrooms and ecstasy, for psychiatric help.  Medical cannabis and psychedelics manufacturer Incannex Healthcare (ASX: IHL) wasted no time and announced the launch of the first psychedelic-assisted psychotherapy clinic.

    Read More
    Public
  • Appen teams up with Reka to help organisations develop generative AI tools
    • News

    Appen teams up with Reka to help organisations develop generative AI tools

    That people are using ChatGPT to generate flirty messages for their Tinder matches is evidence that the generative AI tool has more of a human edge than one can imagine. And that’s possible thanks to the large language models (or LLMs) that go into its making.  To get at the forefront of the action, machine

    Read More
    Public
  • My Rewards to acquire digital marketing agency for $1.8 million
    • News

    My Rewards to acquire digital marketing agency for $1.8 million

    In a bid to diversify its revenue sources, loyalty and engagement rewards provider My Rewards International (ASX: MRI) is set to acquire digital marketing agency Frankly.  Frankly is a Melbourne-based digital marketing agency, offering a range of services including lead generation, search engine marketing (SEM), web development, creative design and campaign reporting. Frankly has provided

    Read More
    Public
  • «
  • ‹
  • 111
  • 112
  • 113
  • 114
  • 115
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.